|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.740 USD | -2.25% |
|
-6.95% | -74.03% |
| 25-09-11 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 25-04-01 | GRI Bio Prices up to $13 Million Equity Offering | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 5.95 | 7.02 | 6.95 |
| Spread/Res. | -70.76% | -75.21% | -74.96% |
| Spread/Supp. | +102.89% | +102.89% | +29.25% |
| Support | 0.8576 | 0.8576 | 1.346 |
- Stock Market
- Stocks
- GRI Stock
- Charts GRI BIOPAR
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
